logo-loader
AQSE:INC

Incanthera Ltd

Receive alerts
Market:
AQSE
Market Cap:
-
Price
16.00 GBX
Change
0.00%
52 weeks high
-
52 weeks low
-

In brief

A revolutionary oncology company, targeting tumours through unique technologies.

Incanthera is committed to the development of novel treatments for solid tumours (cancers), and licensing these to large pharmaceutical companies. Operating from Manchester, with research facilities in Bradford and Salford, Incanthera Ltd was established from the University of Bradford’s Institute of Cancer Therapeutics (www.cancer.brad.ac.uk).

Deep dive We explore the investor case for growth companies

Snapshot

The company is a spin-out from Bradford University’s Institute of Cancer Therapeutics

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Incanthera's skin cancer treatment Sol the first in a pipeline of therapeutics

“The model is to build a portfolio of revenue-generating licences not a series of never-ending clinical studies,

on 8/6/20